dc.date.accessioned | 2019-03-27T15:58:43Z | |
dc.date.accessioned | 2022-10-18T22:14:19Z | |
dc.date.available | 2019-03-27T15:58:43Z | |
dc.date.available | 2022-10-18T22:14:19Z | |
dc.date.created | 2019-03-27T15:58:43Z | |
dc.date.issued | 2016 | |
dc.identifier | http://hdl.handle.net/10533/234543 | |
dc.identifier | 1140553 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/4465900 | |
dc.description.abstract | Background: Dendritic cells (DCs) are antigen presenting cells, able to initiate adaptive
immune responses or induce specific tolerance, depending on their maturation/activation
status. DCs with tolerance-promoting capacities (tolDCs) represent a promisin | |
dc.language | eng | |
dc.relation | 30° | |
dc.relation | info:eu-repo/grantAgreement/Fondecyt/1140553 | |
dc.relation | Reunión Anual de La Sociedad de Biología Celular De Chile | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.title | Identifying markers of tolerogenicity in dexamethasone-modulated monophosphoryl lipid
a-activated dendritic cells. | |
dc.type | Ponencia | |